Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00841464 · ClinicalTrials.gov registry record

Study on the Effect of External Magnetic Stimulation on Patients With Parkinson's Disease

A clinical trial of Parkinson's Disease, sponsored by Parkinson's Disease Research, Education, and Clinical Center, Philadelphia.

Completed
Registry status
20
Enrollment target
1
Study location

NCT00841464: Completed study of Parkinson's Disease, sponsored by Parkinson's Disease Research, Education, and Clinical Center, Philadelphia.

NCT00841464 is a study of Parkinson's Disease that has completed, run by Parkinson's Disease Research, Education, and Clinical Center, Philadelphia. The registered enrollment target is 20 participants, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00841464, a study of Parkinson's Disease, has completed, sponsored by Parkinson's Disease Research, Education, and Clinical Center, Philadelphia.

COMPLETED
Registry status
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to test the usefulness of external magnetic stimulation (EMS) for treating the motor, cognitive, and neuropsychiatric symptoms of Parkinson's disease (PD). Participants with Parkinson's disease will be recruited at the PADRECC of the Philadelphia VA Medical Center. Enrolled participants will be randomly assigned to receive either active external magnetic stimulation or fake stimulation. The external magnetic stimulation is delivered by wearing a helmet that is embedded with many small circuits which produce a very small magnetic field around the head. The helmet is to be worn daily for two minutes immediately before bedtime for three months in a row. The helmet is for investigational use only and has not been approved for use by the FDA.

Conditions Studied

Study Locations (1)

Pennsylvania

  • Philadelphia VA Medical Center - Philadelphia

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2009-03
Est. Completion 2011-05

What the finished NCT00841464 record still lists

NCT00841464 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00841464 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00841464 about?

NCT00841464 is a clinical study titled "Study on the Effect of External Magnetic Stimulation on Patients With Parkinson's Disease". The purpose of this research study is to test the usefulness of external magnetic stimulation (EMS) for treating the motor, cognitive, and neuropsychiatric symptoms of Parkinson's disease (PD). Participants with Parkinson's disease will be recruited at the PADRECC of the Philadelphia VA Medical Cen...

What is the current status of trial NCT00841464?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2009-03. Estimated completion is 2011-05.

What conditions does trial NCT00841464 study?

This clinical trial studies the following conditions: Parkinson's Disease.

Who is sponsoring clinical trial NCT00841464?

This trial is sponsored by Parkinson's Disease Research, Education, and Clinical Center, Philadelphia, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00841464 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00841464's enrollment target sits among peer trials

20 129th of 158 higher than 24 of 158 other Parkinson's Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00841464, the US trial registry maintained by the National Library of Medicine. NCT00841464 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.